Stratasys completes US rollout of 3D-printed imaging support material

Core Insights - Stratasys has fully commercialized its 3D printed RadioMatrix technology in the US, enabling clinicians to create patient-specific models with customizable visibility on X-ray imaging [1][2] - The technology aims to enhance imaging education and training by providing controlled environments for research and surgical planning [2][3] Group 1: Technology and Applications - RadioMatrix is the first 3D printed material that allows control over radiopacity, facilitating the production of ultra-realistic models for radiologists and device manufacturers [1][3] - The collaboration between Stratasys and Siemens Healthineers demonstrated that RadioMatrix phantoms can closely replicate human tissue in CT imaging, with deviations as low as single Hounsfield units in critical areas [3][4] - The use of 3D anatomic models as surgical guides has been shown to reduce surgical time by an average of 62 minutes and save costs of $3,720 per case [6] Group 2: Market Growth and Collaborations - The medical 3D printing market is projected to grow at a compound annual growth rate (CAGR) of 21%, reaching a valuation of $4 billion by 2026, up from $2 billion in 2022 [5] - Stratasys is collaborating with CollPlant Biotechnologies to develop 3D-printed breast implants and with FluidForm Bio to advance 3D printing of human cardiac tissue [7]